Rankings
▼
Calendar
CAI Q4 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
Q4 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$59M
+7.8% YoY
Gross Profit
$38M
65.4% margin
Operating Income
$25M
42.9% margin
Net Income
$16M
27.5% margin
EPS (Diluted)
$0.76
QoQ Revenue Growth
-0.7%
Cash Flow
Operating Cash Flow
$35M
Free Cash Flow
-$46M
Stock-Based Comp.
$521,000
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$1.4B
Stockholders' Equity
$442M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$59M
$55M
+7.8%
Gross Profit
$38M
$36M
+5.4%
Operating Income
$25M
$25M
+0.5%
Net Income
$16M
$16M
+3.7%
← FY 2014
All Quarters
Q1 2015 →